[go: up one dir, main page]

JP2004175680A - Mineral-containing composition having improving effect on biological balance - Google Patents

Mineral-containing composition having improving effect on biological balance Download PDF

Info

Publication number
JP2004175680A
JP2004175680A JP2002340508A JP2002340508A JP2004175680A JP 2004175680 A JP2004175680 A JP 2004175680A JP 2002340508 A JP2002340508 A JP 2002340508A JP 2002340508 A JP2002340508 A JP 2002340508A JP 2004175680 A JP2004175680 A JP 2004175680A
Authority
JP
Japan
Prior art keywords
suppression
mineral
containing composition
aware
suppressing
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2002340508A
Other languages
Japanese (ja)
Inventor
Hideo Someya
秀男 染谷
Noriro Sato
紀朗 佐藤
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Marine Bio Co Ltd Japan
Original Assignee
Marine Bio Co Ltd Japan
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Marine Bio Co Ltd Japan filed Critical Marine Bio Co Ltd Japan
Priority to JP2002340508A priority Critical patent/JP2004175680A/en
Publication of JP2004175680A publication Critical patent/JP2004175680A/en
Pending legal-status Critical Current

Links

Landscapes

  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Abstract

<P>PROBLEM TO BE SOLVED: To obtain a mineral-containing composition, easily ingesting minerals in daily life and reducing patients suffering from osteoporosis, patients suffering from hypertension, patients suffering from hypercholesterolemia, patients suffering from high neutral fats, patients suffering from heart diseases or reserves of these diseases. <P>SOLUTION: This mineral-containing composition comprises a coral fossil produced from the natural world or a mineral derived from marine organisms in which calcium in limestone produced from the marine organisms is substituted with magnesium in the sea and converted into the mineral. The composition has improving effects on biological balance such as enhancing of bone density, a decrease in blood pressure, lowering of total cholesterol, lowering of neutral fats, an increase in HDL (high density lipoprotein), suppression of palpitation, suppression of blink, suppression of headache or amelioration of edema of hands and feet/faces. <P>COPYRIGHT: (C)2004,JPO

Description

【0001】
【発明の属する技術分野】
本発明は、骨密度強化、血圧低下、総コレステロール低下、中性脂肪低下、HDL増加、不整脈の抑制、動悸抑制、瞬き抑制、頭痛抑制、手足・顔の浮腫改善、不安や怒りの抑制、いらいらの抑制、興奮の抑制、肩こりの抑制、だるさの抑制、ぼんやり感の抑制、傾眠の抑制、脳のα波増加、胃酸中和による胸焼けや胃部不快感の改善、高尿酸値の低下、腎臓病に付随する血圧上昇の抑制、高カリウム血漿の抑制、アシドーシスの抑制、高リン血漿の抑制、浮腫抑制、貧血抑制の作用を有することを特徴とする生体バランス改善効果を備えたミネラル含有組成物に関するものである。更に詳しくは、天然から産出されるサンゴ化石又は、海洋生物由来鉱物の利用技術に関するものである。
【0002】
【従来の技術】
日本には現在1000万人の骨粗しょう症患者、1200万人の高血圧患者、500万人の高脂血漿症患者、50万人の腎臓病患者、800万人の胃腸病患者、多数の高中性脂肪病及び心臓病患者、多数の高尿酸患者、多数の更年期症状患者がいると言われている。骨粗しょう症、高血圧症、高脂血漿症、高中性脂肪症、心臓病、高尿酸血症などは遺伝性の他、偏った食生活と運動不足などに起因する生活習慣病とも言われている。従って、それら疾患は日常の食生活を十分配慮する事により予防可能な疾患である。
【0003】
また、筋肉のれん縮が原因と言われている瞼の瞬きや頭痛、手足・顔の浮腫はマグネシウム不足によると考えられている。不安や怒り、いらいら、興奮などの原因である脳のα波低下などはカルシウムとマグネシウム不足によると考えられている。腎臓病に付随する血圧上昇、高カリウム血漿、アシドーシス、高リン血漿、浮腫、貧血などはカルシウムとマグネシウムの摂取不足と考えられている。さらに、胸焼けや胃部不快感、高尿酸値よる各種結石の生成と痛風は、アルカリ性食品の摂取不足と考えられている。
【0004】
【発明が解決しようとする課題】
従って、このようなミネラルを日常生活の中で気軽に摂取できる天然の産物があれば、骨粗しょう症、高血圧症、高脂血漿症、高中性脂肪症、心臓病、高尿酸血症、胃腸病、更年期症やそれらの疾患の予備軍を減らすことが出来る。
【0005】
ここに本出願発明者は各種天然の産物でこのような効果を有するものを検討した結果、本願発明に到達したものであり、本願発明の課題は、日常生活の中で気軽に摂取できる天然産物であって、骨密度強化、血圧低下、総コレステロール低下、中性脂肪低下、HDL増加、不整脈の抑制、動悸抑制、瞬き抑制、頭痛抑制、手足・顔の浮腫改善、不安や怒りの抑制、いらいらの抑制、興奮の抑制、肩こりの抑制、だるさの抑制、ぼんやり感の抑制、傾眠の抑制、脳のα波増加、胃酸中和による胸焼けや胃部不快感の改善、高尿酸値の低下、腎臓病に付随する血圧上昇の抑制、高カリウム血漿の抑制、アシドーシスの抑制、高リン血漿の抑制、浮腫抑制、貧血抑制などの生体バランス改善効果を備えたミネラル含有組成物を提供することにある。
【0006】
【課題を解決するための手段】
上記課題を解決するために、本発明を適用したミネラル含有組成物は、天然から産出されたサンゴ化石、又は海洋生物から生成した石灰岩中のカルシウムが海中のマグネシウムで置換されて鉱物化してなる海洋生物由来の鉱物を含有し、骨密度強化、血圧低下、総コレステロール低下、中性脂肪低下、HDL増加、不整脈の抑制、動悸抑制、瞬き抑制、頭痛抑制、手足・顔の浮腫改善、不安や怒りの抑制、いらいらの抑制、興奮の抑制、肩こりの抑制、だるさの抑制、ぼんやり感の抑制、傾眠の抑制、脳のα波増加、胃酸中和による胸焼けや胃部不快感の改善、高尿酸値の低下、腎臓病に付随する血圧上昇の抑制、高カリウム血漿の抑制、アシドーシスの抑制、高リン血漿の抑制、浮腫抑制、貧血抑制などの生体バランス改善効果を備えていることを特徴とする。
【0007】
本発明において、前記サンゴ化石または前記海洋生成物由来の鉱物には、カルシウムとマグネシウムが2対1から19対1の割合で含まれていることが好ましい。
【0008】
本発明において、更に、杜仲葉配糖体、ラクトトリペプチド、サーデンペプチド、かつお節オリゴペプチド、難消化デキストリン、グロビン蛋白分解物、ジアシルグリセロール、キトサン、大豆蛋白質、低分子アルギン酸ナトリウム、テアニン、カテキン、フィトステロールのうち少なくとも1つの成分が配合されていることが好ましい。
【0009】
本発明において、更に、ザクロ、ガラナ、セイヨウオトギリソウ、エゾウコギ、セイヨウカノコソウ、トケイソウ、カミツレ、ホップ、レモンバーム、ローズマリー、アロエベラ、コウジン、ニガウリ、ラベンダー、マリーゴールド、カモミール、パッションフラワー、マリアザミ、ヒマワリ、キャックロウ、イチョウ、ブドウ種子、ブラックコホシュ、紅花、オレゴングレープ、ラベンダー、ヒマワリ、エキナキア、キャックロウ、カレンジュラ、スギナ、ツボクサ、リュウガンニク、メドスイート、アンジェリカ、トケイソウ、お茶、ウーロン茶、バーベイン、ホワイトウイロー、カギカズラのエキスのうち少なくとも1つの成分が配合されていることが好ましい。
【0010】
本発明において、更に、銅酵母、セレン酵母、マンガン酵母のうち少なくとも1つの成分が配合されていることが好ましい。
【0011】
【発明の実施の形態】
本発明に係るミネラル含有組成物は、天然から産出されたサンゴ化石、又は海洋生物から生成した石灰岩中のカルシウムが海中のマグネシウムで置換されて鉱物化してなる海洋生物由来の鉱物を含有しており、以下、各種臨床結果などを示すように、骨密度強化、血圧低下、総コレステロール低下、中性脂肪低下、HDL増加、不整脈の抑制、動悸抑制、瞬き抑制、頭痛抑制、手足・顔の浮腫改善、不安や怒りの抑制、いらいらの抑制、興奮の抑制、肩こりの抑制、だるさの抑制、ぼんやり感の抑制、傾眠の抑制、脳のα波増加、胃酸中和による胸焼けや胃部不快感の改善、高尿酸値の低下、腎臓病に付随する血圧上昇の抑制、高カリウム血漿の抑制、アシドーシスの抑制、高リン血漿の抑制、浮腫抑制、貧血抑制などの生体バランス改善効果を備えている。
【0012】
ここで、サンゴ化石または海洋生成物由来の鉱物としては、カルシウムとマグネシウムが2対1から19対1の割合で含まれているものを用いることが好ましい。
【0013】
また、本発明では、生体バランス改善効果をさらに高めることを目的に、杜仲葉配糖体、ラクトトリペプチド、サーデンペプチド、かつお節オリゴペプチド、難消化デキストリン、グロビン蛋白分解物、ジアシルグリセロール、キトサン、大豆蛋白質、低分子アルギン酸ナトリウム、テアニン、カテキン、フィトステロールのうち少なくとも1つの成分を配合することがある。また、ザクロ、ガラナ、セイヨウオトギリソウ、エゾウコギ、セイヨウカノコソウ、トケイソウ、カミツレ、ホップ、レモンバーム、ローズマリー、アロエベラ、コウジン、ニガウリ、ラベンダー、マリーゴールド、カモミール、パッションフラワー、マリアザミ、ヒマワリ、キャックロウ、イチョウ、ブドウ種子、ブラックコホシュ、紅花、オレゴングレープ、ラベンダー、ヒマワリ、エキナキア、キャックロウ、カレンジュラ、スギナ、ツボクサ、リュウガンニク、メドスイート、アンジェリカ、トケイソウ、お茶、ウーロン茶、バーベイン、ホワイトウイロー、カギカズラのエキスのうち少なくとも1つの成分を配合してもよい。更に、銅酵母、セレン酵母、マンガン酵母のうち少なくとも1つの成分を配合してもよい。
【0014】
このような構成のミネラル含有組成物に関して、臨床試験などを行った結果を以下に説明する。
【0015】
[評価1]
平均年齢45歳の男女22例が、サンゴカルシウム900mg含有錠剤を1日3回、3カ月間摂取した。摂取前の平均血圧は140.2mmHgであったが、3カ月後の平均値は132.5mmHgへ低下した。この集団の平均年齢の正常血圧は139mmHg以下であるので、血圧は正常化したといえる。
【0016】
[評価2]
平均年齢45歳の男女22例が、サンゴカルシウム900mg含有錠剤を1日3回、3カ月間摂取した。摂取前の平均骨密度は0.27025であったが、3カ月後の平均値は0.28856へ上昇した。この集団の平均年齢の正常骨密度は0.27986以上でなので平均骨密度は正常化した。なお、骨密度の測定はアロカ株式会社製AOS−100超音波装置を使用した。
【0017】
[評価3]
平均年齢45歳の男女22例が、サンゴカルシウム900mg含有錠剤を1日3回、3カ月間摂取した。摂取前の平均中性脂肪値は190.3mg/dlであったが、3カ月後の平均値は130.8mg/dlへ低下した。この集団の平均年齢の正常中性脂肪値は55−150mg/dlであるので、平均中性脂肪値は正常化したといえる。
【0018】
[評価4]
平均年齢45歳の男女22例が、サンゴカルシウム900mg含有錠剤を1日3回、3カ月間摂取した。摂取前の平均コレステロール値は229.5mg/dlであったが、3カ月後の平均値は218.8mg/dlへ低下した。この集団の平均年齢の正常コレステロール値は120−220mg/dlであるので、平均コレステロール値は正常化したといえる。
【0019】
[評価5]
平均年齢45歳の男女22例が、サンゴカルシウム900mg含有錠剤を1日3回、3カ月間摂取した。摂取前の平均HDL値は51.7mg/dlであったが、3カ月後の平均値は56.1mg/dlへ上昇した。この集団の平均年齢の正常コレステロール値は50−70mg/dlであるので、平均HDL値はより一層、正常化したといえる。
【0020】
[評価6]
「動悸」を自覚した平均年齢50歳の男女9例が、サンゴカルシウム900mg含有錠剤を1日3回、3カ月間摂取した。摂取前1例が強く、8例が弱く自覚した。3カ月後7例が動悸を全く自覚せず、2例が弱く自覚したが、全体として動悸が改善されたといえる。
【0021】
[評価7]
「瞼の瞬き」を自覚した平均年齢52歳の男女6例が、サンゴカルシウム900mg含有錠剤を1日3回、3カ月間摂取した。摂取前8例が弱く自覚した。3カ月後5例が瞬きを全く自覚せず、1例が弱く自覚したが、全体として瞬きが改善されたといえる。
【0022】
[評価8]
「頭痛」を自覚した平均年齢45歳の男女6例が、サンゴカルシウム900mg含有錠剤を1日3回、3カ月間摂取した。摂取前1例が強く自覚し、5例が弱く自覚した。3カ月後5例が頭痛を全く自覚せず、1例が弱く自覚したが、全体として頭痛が改善されたといえる。
【0023】
[評価9]
手足顔の浮腫を自覚した平均年齢43歳の男女10例が、サンゴカルシウム900mg含有錠剤を1日3回、3カ月間摂取した。摂取前1例が強く自覚し、9例が弱く自覚した。3カ月後5例が浮腫を全く自覚せず、4例が弱く1例が強く自覚したが、全体として手足顔の浮腫が改善されたといえる。
【0024】
[評価10]
「怒り易い」を自覚した平均年齢47歳の男女15例が、サンゴカルシウム900mg含有錠剤を1日3回、3カ月間摂取した。摂取前1例が強く自覚し、14例が弱く自覚した。3カ月後12例が「怒り易い」を全く自覚せず、2例が弱く1例が強く自覚したが、全体として「怒り易い」が改善されたといえる。
【0025】
[評価11]
「不安」を自覚した平均年齢45歳の男女11例が、サンゴカルシウム900mg含有錠剤を1日3回、3カ月間摂取した。摂取前1例が強く自覚し、10例が弱く自覚した。3カ月後7例が「不安」を全く自覚せず、3例が弱く1例が強く自覚したが、全体として「不安」が改善されたといえる。
【0026】
[評価12]
「いらいら」を自覚した平均年齢40歳の男女16例が、サンゴカルシウム900mg含有錠剤を1日3回、3カ月間摂取した。摂取前1例が強く自覚し、10例が普通程度の自覚をし、14例が弱く自覚した。3カ月後7例が「いらいら」を全く自覚せず、9例が弱く自覚したが、全体として「いらいら」が改善されたといえる。
【0027】
[評価13]
「興奮」を自覚した平均年齢42歳の男女11例が、サンゴカルシウム900mg含有錠剤を1日3回、3カ月間摂取した。摂取前1例が強く自覚し、10例が弱く自覚した。3カ月後6例が「興奮」を全く自覚せず、4例が弱く自覚したが、全体として「興奮」が改善されたといえる。
【0028】
[評価14]
「肩こり」を自覚した平均年齢45歳の男女17例が、サンゴカルシウム900mg含有錠剤を1日3回、3カ月間摂取した。摂取前5例が強く自覚し、7例が普通程度の自覚をし、3例が弱く自覚した。3カ月後6例が「肩こり」を全く自覚せず、6例が弱く自覚したが、全体として「肩こり」が改善されたといえる。
【0029】
[評価15]
「だるさ」を自覚した平均年齢43歳の男女14例が、サンゴカルシウム900mg含有錠剤を1日3回、3カ月間摂取した。摂取前7例が普通程度の自覚をし、11例が弱く自覚した。3カ月後5例が「だるさ」を全く自覚せず、8例が弱く自覚したが、全体として「だるさ」が改善されたといえる。
【0030】
[評価16]
「ぼんやり感」を自覚した平均年齢47歳の男女8例が、サンゴカルシウム900mg含有錠剤を1日3回、3カ月間摂取した。摂取前1例が普通程度の自覚をし、7例が弱く自覚した。3カ月後4例が「ぼんやり感」を全く自覚せず、3例が弱く自覚したが、全体として「ぼんやり感」が改善されたといえる。
【0031】
[評価17]
「傾眠」を自覚した平均年齢43歳の男女13例が、サンゴカルシウム900mg含有錠剤を1日3回、3カ月間摂取した。摂取前3例が強く自覚し、10例が普通程度の自覚をした。3カ月後5例が「傾眠」を全く自覚せず、3例が弱く自覚したが、全体として「傾眠」が改善されたといえる。
【0032】
[評価18]
「不整脈」を自覚した平均年齢48歳の男女6例が、サンゴカルシウム900mg含有錠剤を1日3回、3カ月間摂取した。摂取前6例が強く自覚した。3カ月後4例が「不整脈」を全く自覚せず、2例が弱く自覚したが、全体として「不整脈」が改善されたといえる。
【0033】
[評価19]
平均年齢20歳の男女12例が、数字穴埋めゲームなどによるストレスを与えられた後、サンゴカルシウム1500mgを摂取した。一方、同様なストレスを与えられた同様な対照集団は、デキリストリン1500mgを摂取した。脳波は日本電気株式会社EE1000型14チャネル多用脳波計で測定され、脳波を頭部14箇所から導出し、主としてα波の帯域(8−12Hz)の脳波に付き、α波含有量やα波トポグラフィーにより解析した。α波はリラックス状態時出現する脳波であり、増加するとリラックスし「怒り易い」や「不安」が改善されると言われている。
【0034】
サンゴカルシウム1500mgを摂取した集団のα波は、摂取5分後0.0μV、30分後1.0μVに増加した。一方、デキリストリン1500mgを摂取した対照集団のα波は、摂取5分後1.8μV、30分後0.5μVに減少した。
【0035】
このα波をリラックスに重要な右脳だけでみると、サンゴカルシウム1500mg摂取した集団は、5分後が50μVで、10分後は59μVと上昇した。
【0036】
一方、デキリストリン1500mgを摂取した対照集団では、5分後が40μVで、10分後は30μVへ低下した。
【0037】
次に、頭頂のα波についてみると、サンゴカルシウム1500mg摂取した集団は、5分後が2.1μVで、10分後は3.1μV、20分後は3.4と上昇した。一方、デキリストリン1500mgを摂取した対照集団は、5分後が3.0μVで、10分後は2.5μV、20分後は2.0μVへ低下した。
【0038】
[評価20]
20代の男性2名がサンゴカルシウム200mgを含む飴を摂取した。ケミカル機器株式会社製の2チャネルメモリPH測定器を使用し、胃内と噴門部にPHセンサーを設置し、胃内のPHおよび食道下部のPHを測定した。飴摂取前の胃内のPHは1−2で、食道下部PHは6を示した。
【0039】
また、飴を1粒食べると胃内のPHは、3または4に上昇し、食道下部PHは7に上昇した。また、飴2粒、3粒、4粒を食べた時も同様の事が観察された。
【0040】
以上の様にサンゴカルシウム200mgを含む飴により、胃及び食道下部のPHが中和される事が判明したので、臨床試験を実施した。
【0041】
胸焼けの症状を示す平均年齢50代9名がサンゴカルシウム200mgを含む飴を1−2個を摂取した。9例全例に、胸焼け症状の消出が認められた。胃部不快感症状を示す平均年齢50代10名がサンゴカルシウム200mgを含む飴を1−2個を摂取した。2例に胃部不快感症状の消出が認められ、8例に改善が認められた。
【0042】
[評価21]
高尿酸血症の男4名が、サンゴカルシウム900mg含有錠剤を1日3回、またはカルシウム40mgとマグネシウム20mgとを含むPH8−9のサンゴカルシウム水500mlを毎日、6カ月間摂取した。摂取前の血清尿酸値平均は9.0mg/dlであったが、3カ月後、平均値は6.0mg/dl迄低下し、痛風の痛みも軽減し、四肢の結石または尿路結石も改善された。
【0043】
[評価22]
血清クレアチニン値が高い腎臓病の男4例が、サンゴカルシウム900mg含有錠剤を1日3回、3カ月間摂取した。摂取前平均血清クレアチニン値は6.7mg/dlであったが、6カ月後5.5mg/dl迄低下した。また、これらの患者の摂取前平均血圧は、160.21mmHgあったが、6カ月後の平均値は140.54mmHgへ低下した。摂取前平均血清カリウムは5.0mEq/lであったが、3カ月後の平均値は4.0mEq/l迄低下した。
【0044】
[評価23]
腎臓病の男3例が、サンゴカルシウム900mg含有錠剤を1日3回、6カ月間摂取した。摂取前平均リン値は5.0mg/dlであったが、3カ月後は4.2mg/dl迄低下し、浮腫も改善された。
【0045】
又、摂取前平均血清鉄値は40μg/dlであったが、3カ月後は60μg/dl迄増加した。
【0046】
[サンゴカルシウムの摂取形態]
上記の効果を示すサンゴカルシウムの摂取形態としては、単独もしくは他成分との配合における、錠剤、カプセル剤、散剤、顆粒剤、ふりかけ剤の他、飴、ガム、チョコレート、クッキー・スナック、ゼリーなどの菓子類、各種レトルト食品、カレーのルー、シチュウ、麺類、牛乳など各種食品への配合、飲料などである。
【0047】
【発明の効果】
以上説明したように、本発明に係るミネラル含有組成物は、天然から産出されたサンゴ化石、又は海洋生物から生成した石灰岩中のカルシウムが海中のマグネシウムで置換されて鉱物化してなる海洋生物由来の鉱物を含有しており、日常生活の中で気軽に摂取できる。また、骨密度強化、血圧低下、総コレステロール低下、中性脂肪低下、HDL増加、不整脈の抑制、動悸抑制、瞬き抑制、頭痛抑制、手足・顔の浮腫改善、不安や怒りの抑制、いらいらの抑制、興奮の抑制、肩こりの抑制、だるさの抑制、ぼんやり感の抑制、傾眠の抑制、脳のα波増加、胃酸中和による胸焼けや胃部不快感の改善、高尿酸値の低下、腎臓病に付随する血圧上昇の抑制、高カリウム血漿の抑制、アシドーシスの抑制、高リン血漿の抑制、浮腫抑制、貧血抑制などの生体バランス改善効果を備えている。
[0001]
BACKGROUND OF THE INVENTION
The present invention increases bone density, lowers blood pressure, lowers total cholesterol, lowers triglycerides, increases HDL, suppresses arrhythmias, suppresses palpitation, suppresses blinking, suppresses headache, improves edema of limbs / face, suppresses anxiety and anger, irritability Suppression, suppression of excitement, suppression of stiff shoulders, suppression of dullness, suppression of dullness, suppression of somnolence, increase of alpha wave in the brain, improvement of heartburn and stomach discomfort due to neutralization of gastric acid, reduction of high uric acid level, kidney A mineral-containing composition having a biological balance improving effect characterized by suppressing blood pressure elevation associated with disease, inhibiting high potassium plasma, inhibiting acidosis, inhibiting high phosphorus plasma, inhibiting edema, and inhibiting anemia It is about. More specifically, the present invention relates to a technology for utilizing coral fossils produced from nature or marine organism-derived minerals.
[0002]
[Prior art]
There are currently 10 million osteoporosis patients, 12 million hypertensive patients, 5 million hyperlipidemic plasma patients, 500,000 kidney disease patients, 8 million gastrointestinal disease patients, and many high neutrality patients in Japan. It is said that there are patients with steatosis and heart disease, a number of patients with high uric acid, and a number of patients with climacteric symptoms. Osteoporosis, hypertension, hyperlipidemia, hypertriglyceridosis, heart disease, hyperuricemia, etc. are also said to be lifestyle-related diseases due to hereditary diet and lack of exercise. . Therefore, these diseases are diseases that can be prevented by giving careful consideration to daily eating habits.
[0003]
In addition, blinking of the eyelids, headache, and edema of the limbs and face, which are said to be caused by muscle spasm, are thought to be due to magnesium deficiency. It is thought that a decrease in the alpha wave of the brain, which causes anxiety, anger, annoyance, and excitement, is due to a lack of calcium and magnesium. Increased blood pressure, high potassium plasma, acidosis, high phosphorus plasma, edema, anemia, etc. associated with kidney disease are considered to be insufficient intake of calcium and magnesium. Furthermore, heartburn, stomach discomfort, the formation of various stones due to high uric acid levels, and gout are considered insufficient intake of alkaline foods.
[0004]
[Problems to be solved by the invention]
Therefore, if there are natural products that can be easily consumed in daily life, osteoporosis, hypertension, hyperlipidemia, hypertriglyceridosis, heart disease, hyperuricemia, gastrointestinal disease , Reduce menopause and reserves of those diseases.
[0005]
As a result of studying various natural products having such an effect, the present inventor has arrived at the present invention, and the subject of the present invention is a natural product that can be easily consumed in daily life. Bone density enhancement, blood pressure reduction, total cholesterol reduction, triglyceride reduction, HDL increase, arrhythmia suppression, palpitation suppression, blink suppression, headache suppression, limb / face edema improvement, anxiety and anger suppression, irritability Suppression, suppression of excitement, suppression of stiff shoulders, suppression of dullness, suppression of dullness, suppression of somnolence, increase of alpha wave in the brain, improvement of heartburn and stomach discomfort due to neutralization of gastric acid, reduction of high uric acid level, kidney An object of the present invention is to provide a mineral-containing composition having a biological balance improving effect such as suppression of blood pressure increase associated with disease, suppression of high potassium plasma, suppression of acidosis, suppression of high phosphorus plasma, suppression of edema, and suppression of anemia.
[0006]
[Means for Solving the Problems]
In order to solve the above-mentioned problems, a mineral-containing composition to which the present invention is applied is a coral fossil produced from nature, or a marine product in which calcium in limestone produced from marine organisms is mineralized by substituting magnesium in the ocean. Contains biological minerals, strengthens bone density, lowers blood pressure, lowers total cholesterol, lowers neutral fat, increases HDL, suppresses arrhythmia, suppresses palpitation, suppresses blinking, suppresses headache, improves edema of limbs and face, anxiety and anger Suppression, annoyance, suppression of excitement, suppression of stiff shoulders, suppression of dullness, suppression of dullness, suppression of somnolence, increase of alpha waves in the brain, improvement of heartburn and stomach discomfort by neutralization of gastric acid, high uric acid level It has biological balance improvement effects such as reduction of blood pressure, suppression of blood pressure increase associated with kidney disease, suppression of high potassium plasma, suppression of acidosis, suppression of high phosphorus plasma, suppression of edema, suppression of anemia, etc. It is characterized in.
[0007]
In the present invention, the coral fossil or the mineral derived from the marine product preferably contains calcium and magnesium in a ratio of 2: 1 to 19: 1.
[0008]
In the present invention, further, nakanaka leaf glycoside, lactotripeptide, sadden peptide, bonito oligopeptide, indigestible dextrin, globin proteolysate, diacylglycerol, chitosan, soy protein, low molecular weight sodium alginate, theanine, catechin, It is preferable that at least one component of phytosterol is blended.
[0009]
In the present invention, pomegranate, guarana, Hypericum perforatum, Ezoukogi, valerian serrata, passiflora, chamomile, hops, lemon balm, rosemary, aloe vera, kojin, bitter gourd, lavender, marigold, chamomile, passion flower, maria thistle, sunflower, cough Extract Of these, at least one component is preferably blended.
[0010]
In the present invention, it is preferable that at least one component of copper yeast, selenium yeast, and manganese yeast is further blended.
[0011]
DETAILED DESCRIPTION OF THE INVENTION
The mineral-containing composition according to the present invention contains a coral fossil produced from nature, or a mineral derived from marine organisms, in which calcium in limestone produced from marine organisms is mineralized by substituting magnesium in the ocean. In the following, as shown by various clinical results, bone density enhancement, blood pressure reduction, total cholesterol reduction, triglyceride reduction, HDL increase, arrhythmia suppression, palpitation suppression, blink suppression, headache suppression, limb / face edema improvement , Suppression of anxiety and anger, suppression of annoyance, suppression of excitement, suppression of stiff shoulders, suppression of dullness, suppression of dullness, suppression of somnolence, increase of brain alpha waves, improvement of heartburn and stomach discomfort by neutralizing gastric acid , Improvement of biological balance such as reduction of high uric acid level, suppression of blood pressure increase associated with kidney disease, suppression of high potassium plasma, suppression of acidosis, suppression of high phosphorus plasma, suppression of edema, suppression of anemia It is equipped with a.
[0012]
Here, as the coral fossil or marine product-derived mineral, it is preferable to use a mineral containing calcium and magnesium in a ratio of 2: 1 to 19: 1.
[0013]
Moreover, in the present invention, for the purpose of further enhancing the effect of improving the balance of living body, nakanaka leaf glycoside, lactotripeptide, sadden peptide, bonito oligopeptide, indigestible dextrin, globin proteolysate, diacylglycerol, chitosan, At least one component of soy protein, low molecular weight sodium alginate, theanine, catechin, and phytosterol may be blended. Also, pomegranate, guarana, Hypericum perforatum, Ezocogi, valerian fragrance, passiflora, chamomile, hops, lemon balm, rosemary, aloe vera, kojin, bitter gourd, lavender, marigold, chamomile, passion flower, maria thistle, sunflower, ginkgo, ginkgo, ginkgo At least one of seeds, black cohosh, safflower, oregon grape, lavender, sunflower, echinakia, cucklow, calendula, horsetail, boxweed, longannik, med sweet, angelica, passiflora, tea, oolong tea, barbane, white willow, sage One component may be blended. Furthermore, you may mix | blend at least 1 component among copper yeast, selenium yeast, and manganese yeast.
[0014]
The results of clinical tests and the like regarding the mineral-containing composition having such a configuration will be described below.
[0015]
[Evaluation 1]
Twenty-two men and women with an average age of 45 years took tablets containing 900 mg of coral calcium three times a day for three months. The average blood pressure before ingestion was 140.2 mmHg, but the average value after 3 months dropped to 132.5 mmHg. Since the normal blood pressure of the average age of this group is 139 mmHg or less, it can be said that the blood pressure has been normalized.
[0016]
[Evaluation 2]
Twenty-two men and women with an average age of 45 years took tablets containing 900 mg of coral calcium three times a day for three months. The average bone density before ingestion was 0.27025, but the average value after 3 months rose to 0.28856. Since the average bone density of this group was 0.27986 or more, the average bone density was normalized. The bone density was measured using an AOS-100 ultrasonic device manufactured by Aloka Corporation.
[0017]
[Evaluation 3]
Twenty-two men and women with an average age of 45 years took tablets containing 900 mg of coral calcium three times a day for three months. The average triglyceride value before ingestion was 190.3 mg / dl, but the average value after 3 months decreased to 130.8 mg / dl. Since the average triglyceride value of the average age of this population is 55-150 mg / dl, it can be said that the average triglyceride value was normalized.
[0018]
[Evaluation 4]
Twenty-two men and women with an average age of 45 years took tablets containing 900 mg of coral calcium three times a day for three months. The average cholesterol level before ingestion was 229.5 mg / dl, but the average value after 3 months was reduced to 218.8 mg / dl. Since the normal cholesterol value of the average age of this group is 120-220 mg / dl, it can be said that the average cholesterol value was normalized.
[0019]
[Evaluation 5]
Twenty-two men and women with an average age of 45 years took tablets containing 900 mg of coral calcium three times a day for three months. The average HDL value before intake was 51.7 mg / dl, but the average value after 3 months increased to 56.1 mg / dl. Since the normal cholesterol value of the average age of this population is 50-70 mg / dl, it can be said that the average HDL value was further normalized.
[0020]
[Evaluation 6]
Nine men and women with an average age of 50 who were aware of “palpitations” took tablets containing 900 mg of coral calcium three times a day for three months. One patient was aware that one was strong and 8 were weak before ingestion. Three months later, 7 cases were not aware of palpitation at all and 2 cases were weakly aware, but it can be said that palpitation improved as a whole.
[0021]
[Evaluation 7]
Six men and women with an average age of 52 who were aware of “blinks of moths” ingested tablets containing 900 mg of coral calcium three times a day for three months. Eight cases were noticed weakly before ingestion. After 3 months, 5 cases were not aware of the blink at all, and one was weakly aware, but it can be said that the blink was improved as a whole.
[0022]
[Evaluation 8]
Six men and women with an average age of 45 years who were aware of “headache” took tablets containing 900 mg of coral calcium three times a day for three months. One patient was strongly aware before ingestion and five were weakly aware. After 3 months, 5 cases did not notice any headaches, and one case was weakly aware, but it can be said that the headaches as a whole improved.
[0023]
[Evaluation 9]
Ten men and women with an average age of 43 years who were aware of edema on the limbs and face took tablets containing 900 mg of coral calcium three times a day for three months. One patient was strongly aware before ingestion and nine were weakly aware. Three months later, 5 cases were not aware of edema at all, 4 cases were weak and 1 case was strongly aware, but it can be said that edema of the limbs as a whole improved.
[0024]
[Evaluation 10]
Fifteen men and women with an average age of 47 years who were aware of “easy to get angry” took a tablet containing 900 mg of coral calcium three times a day for three months. One patient was strongly aware before ingestion and 14 were weakly aware. Three months later, 12 cases were not aware of “easy to get angry” at all, 2 cases were weak and 1 case was strongly aware, but overall, “easy to get angry” was improved.
[0025]
[Evaluation 11]
Eleven men and women with an average age of 45 who were aware of “anxiety” took tablets containing 900 mg of coral calcium three times a day for three months. One patient was strongly aware before ingestion and 10 were weakly aware. Three months later, 7 cases were not aware of “anxiety” at all, 3 cases were weak and 1 case was strongly aware, but it can be said that “anxiety” was improved as a whole.
[0026]
[Evaluation 12]
Sixteen men and women with an average age of 40 who were aware of “Iraira” took tablets containing 900 mg of coral calcium three times a day for three months. Prior to ingestion, 1 case was strongly aware, 10 cases were normal, and 14 cases were weak. Three months later, 7 cases were not aware of “Iraira” at all and 9 cases were weakly aware, but it can be said that “Iraira” was improved as a whole.
[0027]
[Evaluation 13]
Eleven men and women with an average age of 42 who were aware of “excitement” took coral calcium 900 mg tablets three times a day for three months. One patient was strongly aware before ingestion and 10 were weakly aware. Three months later, 6 cases were not aware of “excitement” at all, and 4 cases were weakly aware, but it can be said that “excitement” improved as a whole.
[0028]
[Evaluation 14]
Seventeen men and women with an average age of 45 years who were aware of “stiff shoulders” took tablets containing 900 mg of coral calcium three times a day for three months. Five cases were strongly aware before ingestion, 7 cases were normal, and 3 cases were weak. Three months later, 6 cases were not aware of “stiff shoulders” at all, and 6 cases were weakly aware, but it can be said that “stiff shoulders” improved as a whole.
[0029]
[Evaluation 15]
Fourteen men and women with an average age of 43, who were aware of “Darusa”, took tablets containing 900 mg of coral calcium three times a day for three months. Seven cases were aware of normal level and 11 cases were weak before taking. Three months later, 5 cases were not aware of "Darusa" at all, and 8 cases were weakly aware, but it can be said that "Darusa" improved as a whole.
[0030]
[Evaluation 16]
Eight men and women with an average age of 47 who were aware of a “dull feeling” ingested tablets containing 900 mg of coral calcium three times a day for three months. One patient had a normal awareness before ingestion and seven were weak. After 3 months, 4 cases were not aware of “blurred feeling” at all, and 3 cases were weakly aware, but it can be said that “blurred feeling” was improved as a whole.
[0031]
[Evaluation 17]
Thirteen men and women with an average age of 43 who were aware of “somnolence” took tablets containing coral calcium 900 mg three times a day for 3 months. Three cases were strongly aware before ingestion and 10 cases were normal. Three months later, 5 cases were not aware of “somnolence” at all, and 3 cases were weakly aware, but it can be said that “somnolence” improved as a whole.
[0032]
[Evaluation 18]
Six men and women with an average age of 48 years who were aware of “arrhythmia” took a tablet containing 900 mg of coral calcium three times a day for three months. 6 cases were strongly aware before ingestion. Three months later, 4 cases were not aware of “arrhythmia” at all, and 2 cases were weakly aware, but it can be said that “arrhythmia” improved as a whole.
[0033]
[Evaluation 19]
Twelve men and women with an average age of 20 years were given 1500 mg of coral calcium after being stressed by a number filling game. On the other hand, a similar control group given similar stress took 1500 mg of dechristlin. The electroencephalogram was measured with an NEC EE1000 14-channel multi-use electroencephalograph, and the electroencephalogram was derived from 14 locations on the head, and was mainly attached to the electroencephalogram in the alpha wave band (8-12 Hz). Analyzed by graphy. An α wave is an electroencephalogram that appears in a relaxed state, and it is said that when it increases, it relaxes and “easy to get angry” and “anxiety” are improved.
[0034]
The α wave of the group ingesting 1500 mg of coral calcium increased to 0.0 μV after 5 minutes and 1.0 μV after 30 minutes. On the other hand, the α wave of the control group ingesting 1500 mg of dechristlin decreased to 1.8 μV after 5 minutes and 0.5 μV after 30 minutes.
[0035]
When the α wave was observed only in the right brain, which is important for relaxation, the population taking 1500 mg of coral calcium increased to 50 μV after 5 minutes and 59 μV after 10 minutes.
[0036]
On the other hand, in the control group ingesting 1500 mg of dechristlin, it decreased to 40 μV after 5 minutes and to 30 μV after 10 minutes.
[0037]
Next, as for the α wave at the top of the head, the population ingesting 1500 mg of coral calcium increased to 2.1 μV after 5 minutes, 3.1 μV after 10 minutes, and 3.4 after 20 minutes. On the other hand, the control group ingesting 1500 mg of dechristlin decreased to 3.0 μV after 5 minutes, 2.5 μV after 10 minutes, and 2.0 μV after 20 minutes.
[0038]
[Evaluation 20]
Two men in their 20s took coral containing 200 mg of coral calcium. Using a 2-channel memory PH measuring device manufactured by Chemical Instruments Co., Ltd., PH sensors were installed in the stomach and cardia, and PH in the stomach and PH in the lower esophagus were measured. The gastric pH before ingestion was 1-2, and the lower esophageal PH was 6.
[0039]
In addition, when one candy was eaten, the pH in the stomach increased to 3 or 4, and the lower esophageal PH increased to 7. Moreover, the same thing was observed when eating 2 grains, 3 grains and 4 grains.
[0040]
As described above, it was found that the sputum containing 200 mg of coral calcium neutralizes PH in the stomach and lower esophagus, so a clinical trial was conducted.
[0041]
Nine people in their 50s with an average age of 50 showing heartburn symptoms took 1-2 sputum containing 200 mg of coral calcium. In all 9 cases, disappearance of heartburn symptoms was observed. Ten people in their 50s with an average age of stomach discomfort symptom ingested 1-2 sputum containing 200 mg of coral calcium. In 2 cases, disappearance of symptoms of stomach discomfort was observed, and in 8 cases, improvement was observed.
[0042]
[Evaluation 21]
Four men with hyperuricemia took tablets containing 900 mg of coral calcium three times a day or 500 ml of PH8-9 coral calcium water containing 40 mg of calcium and 20 mg of magnesium daily for 6 months. The average serum uric acid level before ingestion was 9.0 mg / dl, but after 3 months, the average value decreased to 6.0 mg / dl, reducing gout pain and improving limb stones or urinary tract stones. It was done.
[0043]
[Evaluation 22]
Four men with renal disease who had high serum creatinine levels took tablets containing 900 mg of coral calcium three times a day for three months. The mean serum creatinine value before ingestion was 6.7 mg / dl, but it decreased to 5.5 mg / dl after 6 months. Moreover, although the mean blood pressure before ingestion of these patients was 160.21 mmHg, the average value after 6 months decreased to 140.54 mmHg. The average serum potassium before ingestion was 5.0 mEq / l, but the average value after 3 months decreased to 4.0 mEq / l.
[0044]
[Evaluation 23]
Three men with kidney disease took tablets containing 900 mg of coral calcium three times a day for 6 months. The average phosphorus value before ingestion was 5.0 mg / dl, but after 3 months it decreased to 4.2 mg / dl and edema was also improved.
[0045]
The mean serum iron level before intake was 40 μg / dl, but increased to 60 μg / dl after 3 months.
[0046]
[Intake form of coral calcium]
Coral calcium ingestion that exhibits the above effects includes tablets, capsules, powders, granules, sprinkling agents, candy, gum, chocolate, cookies, snacks, jelly, etc. alone or in combination with other ingredients Examples include confectionery, various retort foods, curry roux, stew, noodles, milk blends, and beverages.
[0047]
【The invention's effect】
As described above, the mineral-containing composition according to the present invention is a coral fossil produced from nature, or a marine organism derived from mineralization by replacing calcium in limestone produced from marine organisms with magnesium in the ocean. It contains minerals and can be consumed easily in daily life. Also, strengthening bone density, lowering blood pressure, lowering total cholesterol, lowering triglycerides, increasing HDL, suppressing arrhythmia, suppressing palpitation, suppressing blinking, suppressing headache, improving edema of the limbs / face, suppressing anxiety and anger, suppressing irritation , Suppression of excitement, suppression of stiff shoulders, suppression of dullness, suppression of dullness, suppression of somnolence, increased brain alpha waves, improvement of heartburn and stomach discomfort due to neutralization of stomach acid, reduction of high uric acid level, kidney disease It has biological balance improvement effects such as suppression of blood pressure increase, suppression of high potassium plasma, suppression of acidosis, suppression of high phosphorus plasma, suppression of edema, and suppression of anemia.

Claims (5)

天然から産出されたサンゴ化石、又は海洋生物から生成した石灰岩中のカルシウムが海中のマグネシウムで置換されて鉱物化してなる海洋生物由来の鉱物を含有し、
骨密度強化、血圧低下、総コレステロール低下、中性脂肪低下、HDL増加、不整脈の抑制、動悸抑制、瞬き抑制、頭痛抑制、手足・顔の浮腫改善、不安や怒りの抑制、いらいらの抑制、興奮の抑制、肩こりの抑制、だるさの抑制、ぼんやり感の抑制、傾眠の抑制、脳のα波増加、胃酸中和による胸焼けや胃部不快感の改善、高尿酸値の低下、腎臓病に付随する血圧上昇の抑制、高カリウム血漿の抑制、アシドーシスの抑制、高リン血漿の抑制、浮腫抑制、貧血抑制の作用を有することを特徴とする生体バランス改善効果を備えたミネラル含有組成物。
Coral fossils produced from nature or marine organism-derived minerals that are mineralized by replacing calcium in limestone produced from marine organisms with magnesium in the ocean,
Strengthening bone density, lowering blood pressure, lowering total cholesterol, lowering triglycerides, increasing HDL, suppressing arrhythmia, suppressing palpitation, suppressing blinking, reducing headache, improving edema of the limbs / face, suppressing anxiety and anger, suppressing irritation, excitement , Suppression of stiff shoulder, suppression of dullness, suppression of somnolence, suppression of somnolence, increase of brain alpha wave, improvement of heartburn and stomach discomfort due to neutralization of stomach acid, decrease in high uric acid level, associated with kidney disease A mineral-containing composition having an effect of improving a biological balance, characterized by suppressing blood pressure increase, high potassium plasma, acidosis, high phosphorus plasma, edema, and anemia.
請求項1において、前記サンゴ化石または前記海洋生成物由来の鉱物には、カルシウムとマグネシウムが2対1から19対1の割合で含まれていることを特徴とする生体バランス改善効果を備えたミネラル含有組成物。The mineral having an effect of improving the balance of living body according to claim 1, wherein the coral fossil or the mineral derived from the marine product contains calcium and magnesium in a ratio of 2: 1 to 19: 1. Containing composition. 請求項1または2において、更に、杜仲葉配糖体、ラクトトリペプチド、サーデンペプチド、かつお節オリゴペプチド、難消化デキストリン、グロビン蛋白分解物、ジアシルグリセロール、キトサン、大豆蛋白質、低分子アルギン酸ナトリウム、テアニン、カテキン、フィトステロールのうち少なくとも1つの成分が配合されていることを特徴とする生体バランス改善効果を備えたミネラル含有組成物。In Claim 1 or 2, further, nakanaka leaf glycoside, lactotripeptide, sadden peptide, bonito oligopeptide, indigestible dextrin, globin proteolysate, diacylglycerol, chitosan, soy protein, low molecular weight sodium alginate, theanine A mineral-containing composition having an effect of improving a biological balance, wherein at least one component of catechin and phytosterol is blended. 請求項1ないし3のいずれかにおいて、更に、ザクロ、ガラナ、セイヨウオトギリソウ、エゾウコギ、セイヨウカノコソウ、トケイソウ、カミツレ、ホップ、レモンバーム、ローズマリー、アロエベラ、コウジン、ニガウリ、ラベンダー、マリーゴールド、カモミール、パッションフラワー、マリアザミ、ヒマワリ、キャックロウ、イチョウ、ブドウ種子、ブラックコホシュ、紅花、オレゴングレープ、ラベンダー、ヒマワリ、エキナキア、キャックロウ、カレンジュラ、スギナ、ツボクサ、リュウガンニク、メドスイート、アンジェリカ、トケイソウ、お茶、ウーロン茶、バーベイン、ホワイトウイロー、カギカズラのエキスのうち少なくとも1つの成分が配合されていることを特徴とする生体バランス改善効果を備えたミネラル含有組成物。The pomegranate, guarana, hypericum perforatum, sorghum, valerian canopy, passiflora, chamomile, hop, lemon balm, rosemary, aloe vera, kojin, garlic, lavender, marigold, chamomile, passion flower , Mariamisami, sunflower, cucklow, ginkgo, grape seed, black cohosh, safflower, oregon grape, lavender, sunflower, echinakia, cucklow, calendula, horsetail, clover, longannik, med sweet, angelica, passiflora, tea, oolong tea, barbein, Mineral-containing composition with an effect of improving the balance of the living body, characterized in that at least one component of white willow and katsura extract is blended . 請求項1ないし4のいずれかにおいて、更に、銅酵母、セレン酵母、マンガン酵母のうち少なくとも1つの成分が配合されていることを特徴とする生体バランス改善効果を備えたミネラル含有組成物。5. The mineral-containing composition having a biological balance improving effect according to any one of claims 1 to 4, further comprising at least one component selected from copper yeast, selenium yeast, and manganese yeast.
JP2002340508A 2002-11-25 2002-11-25 Mineral-containing composition having improving effect on biological balance Pending JP2004175680A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2002340508A JP2004175680A (en) 2002-11-25 2002-11-25 Mineral-containing composition having improving effect on biological balance

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2002340508A JP2004175680A (en) 2002-11-25 2002-11-25 Mineral-containing composition having improving effect on biological balance

Publications (1)

Publication Number Publication Date
JP2004175680A true JP2004175680A (en) 2004-06-24

Family

ID=32703104

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2002340508A Pending JP2004175680A (en) 2002-11-25 2002-11-25 Mineral-containing composition having improving effect on biological balance

Country Status (1)

Country Link
JP (1) JP2004175680A (en)

Cited By (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2007223924A (en) * 2006-02-22 2007-09-06 Coral Biotech Co Ltd Antihypertensive
JP2011073999A (en) * 2009-09-30 2011-04-14 Coral International Kk Bone density increasing agent
EP2574241A1 (en) * 2011-09-30 2013-04-03 E Ethno'prospections Micro-nutritional speciality made of calcium carbonate and plants
CN103109947A (en) * 2013-03-15 2013-05-22 杭州艺福堂茶业有限公司 Black oolong tea bag and preparation method thereof
JP2013116911A (en) * 2007-08-07 2013-06-13 Mg Pharma Kk Hypotensive agent
CN104398867A (en) * 2014-10-28 2015-03-11 刘林强 Pharmaceutical composition treating arrhythmia coronary heart disease
US9446087B2 (en) * 2006-10-24 2016-09-20 David W. Krempin Anti-resorptive and bone building dietary supplements and methods of use
JP2017001966A (en) * 2015-06-05 2017-01-05 株式会社東洋新薬 Blood triglyceride elevation-inhibiting composition
CN107951940A (en) * 2017-11-16 2018-04-24 湖北大学 A kind of antihypertensive drug composition
JP2021080238A (en) * 2019-11-22 2021-05-27 佰吉ジャパン生物技術開発株式会社 Composition that prevents or reduces hyperuricemia and production method thereof

Cited By (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2007223924A (en) * 2006-02-22 2007-09-06 Coral Biotech Co Ltd Antihypertensive
US11207368B2 (en) 2006-10-24 2021-12-28 Murray Mary A Anti-resorptive and bone building dietary supplements and methods of use
US9446087B2 (en) * 2006-10-24 2016-09-20 David W. Krempin Anti-resorptive and bone building dietary supplements and methods of use
JP2013144696A (en) * 2007-08-07 2013-07-25 Mg Pharma Kk Anti-hypertensive agent
JP2013116911A (en) * 2007-08-07 2013-06-13 Mg Pharma Kk Hypotensive agent
JP2011073999A (en) * 2009-09-30 2011-04-14 Coral International Kk Bone density increasing agent
FR2980670A1 (en) * 2011-09-30 2013-04-05 Ethno Prospections E MICRONUTRITIONAL SPECIALTY BASED ON SEDIMENTARY ROCKS AND PLANTS
EP2574241A1 (en) * 2011-09-30 2013-04-03 E Ethno'prospections Micro-nutritional speciality made of calcium carbonate and plants
CN103109947A (en) * 2013-03-15 2013-05-22 杭州艺福堂茶业有限公司 Black oolong tea bag and preparation method thereof
CN104398867A (en) * 2014-10-28 2015-03-11 刘林强 Pharmaceutical composition treating arrhythmia coronary heart disease
JP2017001966A (en) * 2015-06-05 2017-01-05 株式会社東洋新薬 Blood triglyceride elevation-inhibiting composition
CN107951940A (en) * 2017-11-16 2018-04-24 湖北大学 A kind of antihypertensive drug composition
JP2021080238A (en) * 2019-11-22 2021-05-27 佰吉ジャパン生物技術開発株式会社 Composition that prevents or reduces hyperuricemia and production method thereof
WO2021100837A1 (en) * 2019-11-22 2021-05-27 佰吉ジャパン生物技術開発株式会社 Composition for preventing or reducing hyperuricemia, and method for producing same

Similar Documents

Publication Publication Date Title
Šamec et al. Cruciferous (brassicaceae) vegetables
Yadav et al. Determination of exposure and probable ingestion of fluoride through tea, toothpaste, tobacco and pan masala
JP2004175680A (en) Mineral-containing composition having improving effect on biological balance
JP2006036681A (en) Drink having action of inhibiting increase of neutral fat in blood
JP5357372B2 (en) Skin symptom improving agent
JP4672304B2 (en) Lipolysis accelerator
Khater Herbal and Horticultural Remedies:: Gardening for the Elderly and Physically and Mentally Disabled
Windmann Shilajit: the ayurvedic adaptogen for anti-aging and immune power
Nieder et al. Medicinal uses of soil components, geophagia and podoconiosis
Gittleman Super Nutrition for Menopause: Take Control of Your Life and Enjoy New Vitality
KR100584153B1 (en) Constipation solution for improving constipation by using herbal medicine and its manufacturing method
KR20050080501A (en) A making method of health assistance food for high blood pressure, fatness, diabetes patients.
JP2003230360A (en) Ice cream having health enhancement effect and beauty/ diet effect, and method for producing the same
JP5794761B2 (en) Anti-fatigue agent containing sesamin and vitamin E
US20020090419A1 (en) Food formulations with a high calcium content
ES2314636T3 (en) COMPOSITION; USE OF A COMPOSITION AND A PROCEDURE TO PREVENT FAT ABSORPTION.
JP7505831B2 (en) Hypertension improving agent containing seaweed extract, and functional foods, quasi-drugs and medicines containing said hypertension improving agent
Monte The complete guide to natural healing
KR20060054804A (en) Constipation
CN108420891A (en) A kind of composition and its preparation method and application for preventing and/or treating hyperuricemia
Floury et al. Digestion and oral comfort of cheese developed to meet the sensory and nutritional needs of the elderly
KR20200062988A (en) Manufacturing method of balsamic dressing for salad
TW201701889A (en) Urinary system symptom amelioration agent
Hobbs Natural Therapy for Your Liver: Herbs and Other Natural Remedies for a Healthy Liver
JP2025081772A (en) Bloodstream ameliorating composition

Legal Events

Date Code Title Description
A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20050601

A711 Notification of change in applicant

Free format text: JAPANESE INTERMEDIATE CODE: A711

Effective date: 20050601

RD03 Notification of appointment of power of attorney

Free format text: JAPANESE INTERMEDIATE CODE: A7423

Effective date: 20050601

A521 Written amendment

Free format text: JAPANESE INTERMEDIATE CODE: A821

Effective date: 20050601

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20090310

A02 Decision of refusal

Free format text: JAPANESE INTERMEDIATE CODE: A02

Effective date: 20090716